Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Manmika 500mg Injection

Prescription Icon
Prescription Required

Marketer

Aman Healthcare

Salt Composition

Amikacin (500mg)

Overview Manmika 500mg Injection

Cefamika 500mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, skeletal, pulmonary (pneumonia), neurological, and bloodstream infections. Prophylactic use is also indicated in hospitalized individuals. Cefamika 500mg Injection inhibits bacterial proliferation. Administered intravenously (drip) or intramuscularly by a healthcare professional only, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; incomplete courses risk relapse or infection exacerbation. Common adverse effects involve injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant immediate medical consultation. High-dose therapy may induce vertigo, nephrotoxicity, and ototoxicity. Strict adherence to medical guidance is essential, often including regular kidney, hearing, and urine analysis. Use during pregnancy is contraindicated; disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.

Primary Ingredients of Manmika 500mg Injection

No text was provided to rewrite.

Uses of Manmika 500mg Injection

Infections caused by bacteria

Major Benefits of Manmika 500mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Manmika 500mg Injection:

  • Increased blood urea
  • Injection site reactions (pain, swelling, redness)

How to use Manmika 500mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Manmika 500mg Injection works:

The antibiotic injection Manmika 500mg inhibits bacterial proliferation by disrupting the production of crucial proteins necessary for bacterial survival.

SAFETY ADVICE

AlcoholAlcoholSAFE

The concurrent use of Manmika 500mg Injection and alcohol does not produce adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Manmika 500mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The 500mg Manmika Injection poses no known breastfeeding safety concerns. Research in humans indicates minimal drug transfer to breast milk, presenting negligible risk to the infant.

DrivingDrivingUNSAFE

Administering Manmika 500mg Injection may induce drowsiness, visual disturbances, or dizziness, potentially impairing alertness. Driving should be avoided if such effects are experienced.

KidneyKidneyCAUTION

For individuals with impaired kidney function, administering Manmika 500mg Injection requires careful consideration. A modified dosage of Manmika 500mg Injection may be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Manmika 500mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates that dosage modification may be unnecessary for this patient population. However, physician consultation is recommended.

What if you forget to take Manmika 500mg Injection :

Omit a dose of Manmika 500mg Injection? Seek medical advice immediately.

Facts to Know About Manmika 500mg Injection

LabelValue
Type of Compound Amino glycoside antibiotics
Potential for Dependence None.
Type of Medication Agents against infection
Mechanism of Action Amino glycoside antibiotics

FAQs on Manmika 500mg Injection

Manmika 500mg Injection is typically administered for 7 to 10 days. The prescribed dosage, however, is determined by your physician based on your specific medical needs. For optimal results, adhere to your doctor's instructions regarding both dosage and treatment duration. Never adjust your medication without first consulting your doctor.
Administering Manmika 500mg Injection is safe when used according to your physician's prescribed dosage and schedule. Strictly adhere to the prescribed regimen and avoid missed doses. Closely follow your doctor's guidance and report any adverse effects experienced.
Administering Manmika 500mg Injection requires the guidance of a qualified medical professional; self-injection is strictly prohibited. Dosage is determined by your physician based on your specific medical needs. For optimal results, adhere precisely to your doctor's prescribed regimen for Manmika 500mg Injection.
Manmika 500mg Injection must be administered precisely as directed. Exceeding the recommended dosage of Manmika 500mg Injection elevates the likelihood of adverse reactions. Should symptoms worsen during treatment, seek immediate medical advice.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Contact your physician if your condition hasn't improved after completing the prescribed medication regimen. Similarly, seek medical advice if your symptoms worsen during treatment. Your doctor may adjust your dosage or recommend a different medication.
Discontinue Manmika 500mg Injection only upon completion of the prescribed regimen. Continue treatment as directed, even with symptom improvement, as full eradication of the infection may not yet be achieved.
Refrain from alcohol during your Manmika 500mg Injection treatment course. Alcohol may intensify the drowsiness and dizziness sometimes associated with this medication. Should you consume alcohol and subsequently experience adverse effects, seek medical advice.
Manmika 500mg Injection
55
MRP 67
17% off